EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.
Synchronous oligometastatic disease (sOM) has been described as a distinct disease entity; however, there is no consensus on OM definition (OM-d) in non-small-cell lung cancer (NSCLC). A consensus group was formed aiming to agree on a common OM-d that could be used in future clinical trials. A European survey was circulated to generate questions and input for the consensus group meeting.info:eu-repo/semantics/publishe
Sciences bio-médicales et agricoles, Consensus, Non-small cell lung cancer, Oligometastasis
Publisher: 'Elsevier BV'
DOI identifier: 10.1016/j.ejca.2019.09.012
Sorry, we are unable to provide the full text but you may find it at the